Total Payments
$9,247
2024 Payments
$793.04
Companies
50
Transactions
426
Medicare Patients
11,845
Medicare Billing
$820,283
Payment Breakdown by Category
Food & Beverage$7,969 (86.2%)
Travel$767.44 (8.3%)
Education$509.99 (5.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,969 | 405 | 86.2% |
| Travel and Lodging | $767.44 | 3 | 8.3% |
| Education | $509.99 | 9 | 5.5% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$9,247
417 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,268 | 78 | $0 (2024) |
| Teleflex LLC | $1,039 | 18 | $0 (2023) |
| Astellas Pharma US Inc | $965.31 | 34 | $0 (2024) |
| PFIZER INC. | $586.19 | 37 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $565.91 | 20 | $0 (2023) |
| COLOPLAST CORP | $526.98 | 25 | $0 (2024) |
| Amgen Inc. | $385.71 | 18 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $361.58 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $353.61 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $311.82 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $793.04 | 37 | Merck Sharp & Dohme LLC ($96.54) |
| 2023 | $1,133 | 48 | Novartis Pharmaceuticals Corporation ($182.50) |
| 2022 | $1,971 | 56 | Teleflex LLC ($894.59) |
| 2021 | $1,125 | 52 | COLOPLAST CORP ($222.53) |
| 2020 | $876.14 | 46 | Astellas Pharma US Inc ($168.62) |
| 2019 | $1,162 | 66 | Janssen Biotech, Inc. ($310.34) |
| 2018 | $1,254 | 61 | Janssen Biotech, Inc. ($285.81) |
| 2017 | $932.06 | 60 | PFIZER INC. ($198.52) |
All Payment Transactions
426 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $27.18 | General |
| 12/04/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $29.74 | General |
| 12/02/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: UROLOGY | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Oncology | ||||||
| 10/22/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $24.83 | General |
| Category: Prostate cancer | ||||||
| 09/03/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: UROLOGY | ||||||
| 05/28/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Oncology | ||||||
| 05/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/16/2024 | Novo Nordisk Inc | Rivfloza (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Rare Disease | ||||||
| 05/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Oncology | ||||||
| 05/02/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Oncology | ||||||
| 05/01/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $32.73 | General |
| Category: HORMONE THERAPY | ||||||
| 05/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 2,675 | 20,130 | $581,883 | $173,390 |
| 2022 | 46 | 3,109 | 26,711 | $725,838 | $204,367 |
| 2021 | 46 | 2,976 | 25,585 | $664,266 | $178,313 |
| 2020 | 46 | 3,085 | 30,247 | $942,972 | $264,213 |
Total Patients
11,845
Total Services
102,673
Medicare Billing
$820,283
Procedure Codes
183
All Medicare Procedures & Services
183 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 130 | 1,047 | $68,055 | $46,240 | 67.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 338 | 381 | $72,479 | $23,105 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 203 | $59,130 | $17,342 | 29.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 19 | 129 | $96,933 | $17,242 | 17.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 63 | 71 | $37,514 | $12,225 | 32.6% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 40 | 47 | $33,934 | $8,665 | 25.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $22,844 | $6,013 | 26.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 11 | 13 | $15,150 | $4,085 | 27.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 62 | 106 | $8,480 | $3,680 | 43.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $12,040 | $3,462 | 28.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 133 | 159 | $12,720 | $2,865 | 22.5% |
| 51705 | Simple change of bladder tube | Office | 2023 | 36 | 42 | $10,435 | $2,865 | 27.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 203 | 257 | $2,570 | $2,159 | 84.0% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 18 | 20 | $23,483 | $1,682 | 7.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 213 | 249 | $17,536 | $1,647 | 9.4% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 85 | 110 | $3,973 | $1,582 | 39.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 16 | 19 | $3,041 | $1,456 | 47.9% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 317 | 448 | $5,824 | $1,391 | 23.9% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 29 | 29 | $6,119 | $1,286 | 21.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 16 | 16 | $5,392 | $1,236 | 22.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 13 | 13 | $7,700 | $1,150 | 14.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 32 | $3,840 | $1,138 | 29.6% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 11 | 451 | $3,608 | $1,021 | 28.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 26 | $2,860 | $995.02 | 34.8% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 16 | 16 | $4,960 | $950.46 | 19.2% |
About Dr. William Cook, M.D
Dr. William Cook, M.D is a Urology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578583423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Cook, M.D has received a total of $9,247 in payments from pharmaceutical and medical device companies, with $793.04 received in 2024. These payments were reported across 426 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($7,969).
As a Medicare-enrolled provider, Cook has provided services to 11,845 Medicare beneficiaries, totaling 102,673 services with total Medicare billing of $820,283. Data is available for 4 years (2020–2023), covering 183 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Tulsa, OK
- Active Since 07/20/2006
- Last Updated 07/05/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1578583423
Products in Payments
- UroLift System (Device) $822.50
- XTANDI (Drug) $781.13
- PROVENGE (Drug) $611.69
- Erleada (Drug) $551.33
- ERLEADA (Drug) $523.47
- SpeediCath (Device) $342.53
- Nubeqa (Drug) $321.16
- Prolia (Biological) $318.43
- ELIGARD (Drug) $286.74
- KEYTRUDA (Biological) $284.64
- PLUVICTO (Drug) $262.91
- XIAFLEX (Biological) $242.50
- JELMYTO (Drug) $231.98
- UROLIFT (Device) $216.41
- ZYTIGA (Drug) $175.59
- (815) Thiola (Drug) $157.26
- Rezum (Device) $125.66
- LITHOVUE (Device) $107.51
- CONTINENCE CARE (Device) $107.00
- Xtandi (Drug) $95.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Tulsa
Dr. Melanie Ketchandji, M.d, M.D
Urology — Payments: $90,749
Urology $90,749
Scott Litwiller, Md, MD
Urology — Payments: $41,382
Urology $41,382
Dr. Sean Doyle, M.d, M.D
Urology — Payments: $31,400
Urology $31,400
Charles Pritchard, Md, MD
Urology — Payments: $24,283
Urology $24,283
Marc Milsten, Md, MD
Urology — Payments: $23,702
Urology $23,702
Dr. Curtis Powell, M.d, M.D
Urology — Payments: $17,755
Urology $17,755